Da Hee Han, PharmD

All articles by Da Hee Han, PharmD

Non-NK1 receptor antagonists Effective Against Chemotherapy-induced Nausea and Vomiting

General Oncology, Side Effect Management

Additional Method of Administration Approved for Cinvanti in Chemotherapy-Induced Nausea and Vomiting

February 28, 2019

Heron Therapeutics announced that the Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for Cinvanti (aprepitant) to expand administration to include a 2-minute intravenous (IV) injection, in addition to the already approved 30-minute IV infusion.

Skin Cancer, Skin Cancer News

Keytruda Approved for the Adjuvant Treatment of Patients With Stage III Melanoma

Da Hee Han, PharmD

February 26, 2019

Merck announced that the Food and Drug Administration (FDA) has approved Keytruda(pembrolizumab) for the adjuvant treatment of patients with melanoma with involvement of lymph node(s) following complete resection. This marks the first approval for Keytruda in the adjuvant setting and the fourth approval for its use in skin cancers. The approval was supported by data from the phase 3,…

Next post in Skin Cancer

Da Hee Han, PharmD

All articles by Da Hee Han, PharmD

Additional Method of Administration Approved for Cinvanti in Chemotherapy-Induced Nausea and Vomiting

Keytruda Approved for the Adjuvant Treatment of Patients With Stage III Melanoma

A Common Factor Links Mechanisms of Acquired Resistance to Melanoma Treatment